Search

everythinglearnresearchcommunity

for

Search:↓

Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.

Physical activity, height, and smoking affect prostate cancer risk.

A group has developed therapies that show promise for treating cancer and various other conditions.

Nano-sized plant-based chemicals could improve cervical cancer treatment by being more effective and causing fewer side effects than current methods.

Short telomeres contribute to aging and cancer, and while telomerase can delay aging, it may also promote cancer.

Ayurvedic herbs may reduce side effects and improve effectiveness of cancer treatments.

Dihydrotestosterone causes p27 protein breakdown in ovarian and breast cancer cells by binding with SKP2.

An emollient PLUS balm with ADE-G1 significantly improved skin dryness and quality of life in cancer patients with xerosis.

Semecarpus anacardium leaf extracts may offer safe, effective cancer treatment alternatives.

First Korean case of Cronkhite-Canada syndrome with colon cancer and serrated adenoma.

Drinking a lot of alcohol increases the risk of prostate cancer and can worsen the condition.

DHL-HisZnNa may help reduce hair loss from chemotherapy, but more research is needed.

New skin lesions on the scrotum or vulva in patients with a history of internal cancer could indicate rare skin metastasis.

BAY 43-9006 helps control kidney cancer growth but doesn't significantly increase overall survival.

ERG increases SOX9, promoting prostate cancer growth and invasion.

The conclusion is that proper signaling is crucial for hair growth and development, and errors can lead to cancer or hair loss.

Targeted cancer therapies often cause serious skin problems that need careful management.

Male and female skin differ due to hormones, affecting conditions like hair loss, acne, and skin cancer, and suggesting a need for gender-specific treatments.

Selenium and vitamin E supplements have mixed effects on prostate cancer risk and may not be beneficial for everyone.

Vitamin D receptor may help protect against UV-induced skin cancer.

Ginseng may help treat cancer and reduce treatment side effects, but more research is needed.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

The document concludes that side effects from Smoothened inhibitor drugs for skin cancer are reversible and can be managed with a team approach to maintain quality of life.

Spironolactone does not increase cancer risk and may lower prostate cancer risk, but more research is needed.

New treatments for non-small cell lung cancer are being tested, with some already in use, focusing on immune response and targeting cancer cells, but side effects vary.

Taking spironolactone doesn't increase the chance of breast cancer coming back.

Men with vertex baldness may have a higher risk of developing prostate cancer, but more research is needed to confirm this.

New cancer treatments aim to reduce side effects and improve effectiveness.